Download video

Pro Golfer Kelly Baylor-Shelton Shares Her Skin Cancer Story

No views

The Skin Cancer Center

2 days ago

Pro Golfer Kelly Baylor-Shelton Shares Her Skin Cancer Story

Pro Golfer Kelly Baylor-Shelton Shares Her Skin Cancer Story

HER2CLIMB-05: Tucatinib Boosts PFS in HER2+ Metastatic Breast Cancer
0:31
HER2CLIMB-05: Tucatinib Boosts PFS in HER2+ Metastatic Breast Cancer
by OncoAlert 360
PET Tumor Board – Case 3: 62-year-old BRCA2-Positive Prostate Cancer Survivor with PSA Recurrence
12:32
PET Tumor Board – Case 3: 62-year-old BRCA2-Positive Prostate Cancer Survivor with PSA Recurrence
by Grand Rounds in Urology
The Role of the TROP2 Biomarker in Cancer
4:16
The Role of the TROP2 Biomarker in Cancer
by CancerCare
WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. Balazs Halmos
23:59
WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. Balazs Halmos
by OncBrothers: Practice-Changing Cancer Discussions
You Don't Have To Confront Lung Cancer Alone – GO2 for Lung Cancer is Your Go-To (15s)
0:15
You Don't Have To Confront Lung Cancer Alone – GO2 for Lung Cancer is Your Go-To (15s)
by GO2 for Lung Cancer
Presley | GO2 for Lung Cancer Survivor Spotlight
4:06
Presley | GO2 for Lung Cancer Survivor Spotlight
by GO2 for Lung Cancer
26 – The Role of Cancer Screening in Longevity
31:43
26 – The Role of Cancer Screening in Longevity
by GRAIL
102 part2 supplierlabels2
4:04
102 part2 supplierlabels2
by KnowledgeWare Communications Corp.
Oncology here and now with Dr Morgan \& Mr Tyler Kratzer. season 2 episode 2
5:28
Oncology here and now with Dr Morgan \& Mr Tyler Kratzer. season 2 episode 2
by OncoAlert 360
PSA Greater Than 0.2 After 6-12 Months of Treatment for mHSPC Intensified by ARPI
9:10
PSA Greater Than 0.2 After 6-12 Months of Treatment for mHSPC Intensified by ARPI
by GU Oncology Now
Expert Panel Discussion. Part 2 of 3
32:56
Expert Panel Discussion. Part 2 of 3
by CLL Support Association (CLLSA)
Dr Klempner on the FDA Approval of Zolbetuximab for CLDN18.2+, HER2– Gastric or GEJ Adenocarcinoma
2:01
Dr Klempner on the FDA Approval of Zolbetuximab for CLDN18.2+, HER2– Gastric or GEJ Adenocarcinoma
by OncLive
SOHO-02: BAY 2927088, an oral HER2 TKI, for first-line NSCLC
1:03
SOHO-02: BAY 2927088, an oral HER2 TKI, for first-line NSCLC
by VJOncology
Key therapeutic markers in gastroesophageal cancers: HER2, PDL1, MSI \& more
0:40
Key therapeutic markers in gastroesophageal cancers: HER2, PDL1, MSI \& more
by VJOncology
HER2-Mutated Lung Cancer in Brazil: Clinical and Genomic Insights | Oncotarget
1:52
HER2-Mutated Lung Cancer in Brazil: Clinical and Genomic Insights | Oncotarget
by Oncotarget
5 Key Takeaways from the PATHFINDER 2 Study
2:52
5 Key Takeaways from the PATHFINDER 2 Study
by GRAIL
Should you get a second opinion for cancer?
0:30
Should you get a second opinion for cancer?
by The Cancer Guy
Traditional Cancer Treatments
11:01
Traditional Cancer Treatments
by Gary Wortman
#17. Can HER2 testing (and HER2 targeted therapies) help you?
3:53
#17. Can HER2 testing (and HER2 targeted therapies) help you?
by The Cancer Guy
GRAIL President Discusses Gaps and Opportunities in Cancer Care
3:14
GRAIL President Discusses Gaps and Opportunities in Cancer Care
by GRAIL